Benzinga | Oct 25, 2021 08:39AM EDT

RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $291

RBC Capital analyst Frank Morgan maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $273 to $291.